Is There a Role for Serum Human Tissue Kallikrein in Detection of Prostate Cancer?

Urology

Volumn 70, Issue 3, 2007, Pages 519-522

  Ochiai, Atsushi ^a   Shukla, Ashish ^a   Davis, John W ^a   Fritsche, Herbert A ^a   Bhadkamkar, Viju ^a   Babaian, R Joseph ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER SCREENING; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; RANK SUM TEST; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES; TUMOR MARKERS, BIOLOGICAL;

EID: 34648846916     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.04.036     Document Type: Article

References (13)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Ries L.A., Kosary C.L., Hankey B.G., et al. SEER Cancer Statistics Review (1998), National Cancer Institute, Bethesda
3. Hankey B.F., Feuer E.J., Clegg L.X., et al. Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91 (1999) 1017-1024
4. Martin B.J., Cheli C.D., Sterling K., et al. Prostate specific antigen isoforms and human glandular kallikrein 2-which offers the best screening performance in a predominantly black population?. J Urol 175 (2006) 104-107
5. Khan M.A., Partin A.W., Rittenhouse H.G., et al. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0-10.0 ng/ml. J Urol 170 (2003) 723-726
6. Okihara K., Cheli C.D., Partin P., et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 167 (2002) 2017-2024
7. Yousef G.M., and Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 22 (2001) 184-204
8. Diamandis E.P., Okui A., Mitsui S., et al. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res 62 (2002) 295-300
9. Nakamura T., Scorilas A., Stephan C., et al. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res 63 (2003) 6543-6546
10. Adam B.L., Qu Y., Davis J.W., et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62 (2002) 3609-3614
11. Hortin G.L. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?. Clin Chem 51 (2005) 3-5
12. Diamandis E.P., Yousef G.M., and Clements J. New nomenclature for the human tissue kallikrein gene family. Clin Chem 46 (2000) 1855-1858
13. Nakamura T., Mitsui S., Okui A., et al. Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines. Prostate 49 (2001) 72-78